Activation of the Nrf2/ARE signaling pathway protects against palmitic acid-induced renal tubular epithelial cell injury by ameliorating mitochondrial reactive oxygen species-mediated mitochondrial dysfunction
Open Access
- 13 September 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 939149
Abstract
Chronic kidney disease (CKD) is often accompanied by dyslipidemia, and abnormal lipid metabolism in proximal tubule cells is considered closely related to the dysfunction of proximal tubule cells and eventually leads to accelerated kidney damage. Nuclear factor E2-related factor 2 (Nrf2), known as a redox-sensitive transcription factor, is responsible for regulating cellular redox homeostasis. However, the exact role of Nrf2 in dyslipidemia-induced dysfunction of proximal tubule cells is still not fully elucidated. In the present study, we showed that palmitic acid (PA) induced mitochondrial damage, excessive mitochondrial reactive oxygen species (ROS) (mtROS) generation, and cell injury in HK-2 cells. We further found that mtROS generation was involved in PA-induced mitochondrial dysfunction, cytoskeletal damage, and cell apoptosis in HK-2 cells. In addition, we demonstrated that the Nrf2/ARE signaling pathway was activated in PA-induced HK-2 cells and that silencing Nrf2 dramatically aggravated PA-induced mtROS production, mitochondrial damage, cytoskeletal damage and cell apoptosis in HK-2 cells. However, the mitochondrial antioxidant MitoTEMPOL effectively eliminated these negative effects of Nrf2 silencing in HK-2 cells under PA stimulation. Moreover, activation of the Nrf2/ARE signaling pathway with tBHQ attenuated renal injury, significantly reduced mtROS generation, and improved mitochondrial function in rats with HFD-induced obesity. Taken together, these results suggest that the Nrf2/ARE-mediated antioxidant response plays a protective role in hyperlipidemia-induced renal injury by ameliorating mtROS-mediated mitochondrial dysfunction and that enhancing Nrf2 antioxidant signaling provides a potential therapeutic strategy for kidney injury in CKD with hyperlipidemia.Keywords
Funding Information
- National Natural Science Foundation of China
- National Natural Science Foundation of China
This publication has 41 references indexed in Scilit:
- Toward clinical application of the Keap1–Nrf2 pathwayTrends in Pharmacological Sciences, 2013
- Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney diseaseKidney International, 2013
- Altered Mitochondrial Dynamics Contributes to Endothelial Dysfunction in Diabetes MellitusCirculation, 2011
- Signaling pathways in mitochondrial dysfunction and agingMechanisms of Ageing and Development, 2010
- The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic NephropathyDiabetes, 2010
- Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in miceKidney International, 2009
- Urinary Fatty Acids and Liver-Type Fatty Acid Binding Protein in Diabetic NephropathyNephron Clinical Practice, 2009
- The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative DiseaseAntioxidants & Redox Signaling, 2009
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer TherapyClinical Cancer Research, 2009
- Lipoprotein Metabolism and Lipid Management in Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2007